Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 6/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.32 |
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2513481 | 0.79 | LPAR3 (0.45) | LPAR3LPAR2LPAR1PGK1PGK2 | |
| SCHEMBL5963785 | 0.78 | LMNA (0.40) | SMPD1PGK1PGK2 | |
| SCHEMBL10316879 | 0.74 | LPAR3 (0.42) | LPAR3LPAR2LPAR1SMPD1PGK1 | |
| SCHEMBL811703 | 0.72 | LPAR3 (0.55) | LPAR3LPAR2LPAR1PGK1PGK2 | |
| SCHEMBL27985564 | 0.72 | LPAR3 (0.39) | LPAR3LPAR2LPAR1PGK1PGK2 | |
| SCHEMBL28683623 | 0.70 | LPAR3 (0.40) | LPAR3LPAR2LPAR1PGK1PGK2 | |
| SCHEMBL6514945 | 0.69 | LPAR3 (0.52) | LPAR3LPAR2LPAR1PGK1PGK2 | |
| SCHEMBL10317032 | 0.68 | LPAR3 (0.49) | LPAR3LPAR2LPAR1SMPD1 | |
| SCHEMBL5963603 | 0.68 | SMPD1 (0.38) | LPAR3LPAR2LPAR1SMPD1 | |
| SCHEMBL1514200 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2476684-B1 | Method for manufacturing alkyl-phosphates | LANXESS DEUTSCHLAND GMBH (DE) | 2017-07-19 | — | — | EP | claimed |
| EP-2476685-B1 | Method for manufacturing alkyl-phosphates | LANXESS DEUTSCHLAND GMBH (DE) | 2017-08-02 | — | — | EP | disclosed |
| EP-2476686-B1 | Method for manufacturing alkyl-phosphates | LANXESS DEUTSCHLAND GMBH (DE) | 2017-08-02 | — | — | EP | disclosed |
| EP-2476684-B1 | Method for manufacturing alkyl-phosphates | LANXESS DEUTSCHLAND GMBH (DE) | 2017-07-19 | — | — | EP | disclosed |
| US-8846967-B2 | Process for preparing alkyl phosphates | LANXESS DEUTSCHLAND GMBH (DE) | 2014-09-30 | — | — | US | disclosed |
| EP-2479179-A1 | Process for the preparation of alkylphosphates | LANXESS Deutschland GmbH (DE) | 2012-07-25 | — | — | EP | disclosed |
| EP-2479178-A1 | Process for the preparation of alkylphosphates | LANXESS Deutschland GmbH (DE) | 2012-07-25 | — | — | EP | disclosed |
| EP-2479180-A1 | Process for the preparation of alkylphosphates | LANXESS Deutschland GmbH (DE) | 2012-07-25 | — | — | EP | disclosed |
| US-20120184764-A1 | Process for preparing alkyl phosphates | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-19 | — | — | US | disclosed |
| US-20120184766-A1 | Process for preparing alkyl phosphates | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-19 | — | — | US | disclosed |
| US-20120184765-A1 | Process for preparing alkyl phosphates | LANXESS DEUTSCHLAND GMBH (DE) | 2012-07-19 | — | — | US | disclosed |
| EP-2476685-A1 | Method for manufacturing alkyl-phosphates | Lanxess Deutschland GmbH (DE) | 2012-07-18 | — | — | EP | disclosed |
| EP-2476686-A1 | Method for manufacturing alkyl-phosphates | Lanxess Deutschland GmbH (DE) | 2012-07-18 | — | — | EP | disclosed |
| EP-2476684-A1 | Method for manufacturing alkyl-phosphates | Lanxess Deutschland GmbH (DE) | 2012-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120184764-A1 | Process for preparing alkyl phosphates | PNKP, PHOSPHO1, DCTPP1 | LPAR3 361/4885LPAR2 430/4885LPAR1 409/4885 |
| US-20120184766-A1 | Process for preparing alkyl phosphates | PHOSPHO1, PNKP, PLCB3 | LPAR3 354/4885LPAR2 380/4885LPAR1 418/4885 |
| US-20120184765-A1 | Process for preparing alkyl phosphates | PNKP, PHOSPHO1, DCTPP1 | LPAR3 361/4885LPAR2 430/4885LPAR1 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.